Dendritic Tau in Alzheimer’s Disease

Ittner, Arne, Ittner, Lars M.·2018·Neuron

Cited by (280)

Items 101–200 of 280

  1. Enhanced Tau Protein Translation by Hyper-Excitation
    S. Kobayashi, Toru Tanaka, Yoshiyuki Soeda, A. Takashima · 2019 · Frontiers in Aging Neuroscience
  2. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy
    Xiaomin Yin, Yuanyuan Li, Xing Fan, Fang Huang, Yanyan Qiu, Chenhao Zhao, Zheng Zhou, Qun Gu, Liye Xia, Junze Bao et al. · 2022 · Molecular Psychiatry
  3. Clusterin is a Potential Therapeutic Target in Alzheimer’s Disease
    Nazhakaiti Palihati, Yuanhong Tang, Yajuan Yin, Ding Yu, Gang Liu, Zhenzhen Quan, Junjun Ni, Yan Yan, Hong Qing · 2023 · Molecular Neurobiology
  4. Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
    Toshihiko Tashima · 2022 · Pharmaceutics
  5. Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
    Beatriz Gomez Perez‐Nievas, Louisa Johnson, Paula Beltran-Lobo, Martina M. Hughes, Luciana Gammallieri, Francesca Tarsitano, Monika A. Myszczynska, Irina Vázquez-Villaseñor, María Jiménez-Sánchez, Claire Troakes et al. · 2021 · Journal of Neuroinflammation
  6. CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis
    Aikaterini Theodorou, Ioanna Tsantzali, Maria‐Ioanna Stefanou, Simona Sacco, Aristeidis H. Katsanos, Ashkan Shoamanesh, Theodoros Karapanayiotides, Ioanna Koutroulou, Polyxeni Stamati, David John Werring et al. · 2024 · European Stroke Journal
  7. Epigenetic Modulation on Tau Phosphorylation in Alzheimer’s Disease
    Chao-Chao Yu, Tao Jiang, Aofei Yang, Yanjun Du, Miao Wu, Li-Hong Kong · 2019 · Neural Plasticity
  8. Unveiling the role of astrogliosis in Alzheimer’s disease Pathology: Insights into mechanisms and therapeutic approaches
    Mohit Paidlewar, Sneha Kumari, Rishika Dhapola, Prajjwal Sharma, Dibbanti HariKrishnaReddy · 2024 · International Immunopharmacology
  9. Intracellular accumulation of tau inhibits autophagosome formation by activating TIA1-amino acid-mTORC1 signaling
    Mengzhu Li, En-Jie Liu, Qiuzhi Zhou, Shihong Li, Shijie Liu, Haitao Yu, Qihang Pan, Fei Sun, Ting He, Wei-Jin Wang et al. · 2022 · Military Medical Research
  10. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice
    Yao Yi, Yanmin Chang, Shaomin Li, Jiahui Zhu, Yanqing Wu, Xingjun Jiang, Lulu Li, Ruitian Liu, Rong Ma, Gang Li · 2023 · Brain Research Bulletin
  11. Neurogranin and neuronal pentraxin receptor as synaptic dysfunction biomarkers in Alzheimer’s disease
    Dulewicz, Maciej, Kulczyńska-Przybik, Agnieszka, Słowik, Agnieszka, Borawska, Renata, Mroczko, Barbara · 2021 · Journal of Clinical Medicine
  12. Heparan Sulfate Proteoglycans in Tauopathy
    Yanan Zhu, Lauren A. Gandy, Fuming Zhang, Jian Liu, Chunyu Wang, Laura J. Blair, Robert J. Linhardt, Lianchun Wang · 2022 · Biomolecules
  13. Sleep Disruption Precedes Forebrain Synaptic Tau Burden and Contributes to Cognitive Decline in a Sex-Dependent Manner in the P301S Tau Transgenic Mouse Model
    Shenée C. Martin, Kathryn K. Joyce, Julia Sparks Lord, Kathryn M. Harper, Viktoriya D. Nikolova, Todd J. Cohen, Sheryl S. Moy, Graham H. Diering · 2024 · eNeuro
  14. The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC‐derived neurons to amyloid beta and phosphorylated tau‐induced neuronal dysfunction
    Sarah Buchholz, Mohamed Aghyad Al Kabbani, Michael Bell‐Simons, Lena Kluge, Cagla Cagmak, Jennifer Klimek, Natja Haag, Lukas da Cruz Carvalho Iohan, Audrey Coulon, Marcos R. Costa et al. · 2025 · Alzheimer s & Dementia
  15. Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s disease and frontotemporal lobar degeneration
    Anna Cranston, Adrianna Wysocka, Marta Steczkowska, Maciej Zadrożny, Ewelina Pałasz, Charles R. Harrington, Franz Theuring, Claude M. Wischik, Gernot Riedel, Grażyna Niewiadomska · 2020 · Brain Communications
  16. Development of tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases
    Jingfen Su, Yue Xiao, Xiaochuan Wang, Jie Zheng, Jian‐Zhi Wang · 2024 · Medicine Plus
  17. A new paradigm for regulation of protein phosphatase 2A function via Src and Fyn kinase–mediated tyrosine phosphorylation
    Jean‐Marie Sontag, Diana Schuhmacher, Goce Taleski, Anthony Jordan, Sarah Zafar Khan, Alexander Hoffman, Rey J. Gomez, Matthew D. Mazalouskas, Steven K. Hanks, Benjamin W. Spiller et al. · 2022 · Journal of Biological Chemistry
  18. Microtubule affinity regulating kinase (MARK/Par1) isoforms differentially regulate Alzheimer-like TAU missorting and Aβ-mediated synapse pathology
    Jana Chudobová, Hans Zempel · 2022 · Neural Regeneration Research
  19. Genomics: New Light on Alzheimer’s Disease Research
    Yeong Ju Jung, Yoon Ha Kim, Mridula Bhalla, Sung Bae Lee, Jinsoo Seo · 2018 · International Journal of Molecular Sciences
  20. Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons
    Jessica Binder, Praveen N. Chander, Vojo P. Deretic, Jason Porter Weick, Kiran Bhaskar · 2020 · PLoS ONE
  21. Navigating the Maze of Alzheimer’s disease by exploring BACE1: Discovery, current scenario, and future prospects
    Faiza Iram, Mohammad Shahid, Jaoud Ansari, Ghulam Md Ashraf, Md. Imtaiyaz Hassan, Asimul Islam · 2024 · Ageing Research Reviews
  22. Anti-Alzheimer’s Materials Isolated from Marine Bio-resources: A Review
    Anuruddhika Udayangani Rathnayake, Racheal Abuine, Yong‐Jae Kim, Hee‐Guk Byun · 2019 · Current Alzheimer Research
  23. Natural Bioactive Products and Alzheimer’s Disease Pathology: Lessons from Caenorhabditis elegans Transgenic Models
    María D. Navarro‐Hortal, José M. Romero‐Márquez, Safa Osta, Victoria Jiménez-Trigo, Pedro Muñoz-Ollero, Alfonso Varela‐López · 2022 · Diseases
  24. Tau: More than a microtubule‐binding protein in neurons
    Alejandra del C. Alonso, Abdeslem El Idrissi, Robert F. Candia, Viktoriya Morozova, Frida E. Kleiman · 2023 · Cytoskeleton
  25. Sequence and trajectory of early Alzheimer’s disease-related tau inclusions in the hippocampal formation of cases without amyloid-β deposits
    Heiko Braak, Benjamin Mayer, Simone Feldengut, Michael Schön, Kelly Del Tredici · 2025 · Acta Neuropathologica
  26. RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D-galactose and aluminum-induced Alzheimer’s disease-like rat model
    Han, Fei, Xu, Hui, Shen, Jun-Xian, Pan, Chuan, Yu, Zong-Hao, Chen, Jing-Jing, Zhu, Xiu-Ling, Cai, Ya-Fei, Lu, Ya-Ping · 2020 · Acta Neurobiologiae Experimentalis
  27. Impaired Cognitive Flexibility Induced by Chronic Cerebral Hypoperfusion in the 5XFAD Transgenic Mouse Model of Mixed Dementia
    Min‐Soo Kim, Jihye Bang, Bu‐Yeo Kim, Won Kyung Jeon · 2021 · The Journals of Gerontology Series A
  28. Alzheimer’s disease basics: we all should know
    S.K. Das · 2025 · Neurological Research
  29. Rise and fall of peroxisomes during Alzheimer´s disease: a pilot study in human brains
    Eugen Semikasev, Barbara Ahlemeyer, Till Acker, Anne Schänzer, Eveline Baumgart‐Vogt · 2023 · Acta Neuropathologica Communications
  30. Tau suppresses neuronal activity in vivo, even before tangles form
    Marc Aurel Busche · 2019 · Brain
  31. The effect of crocin on apoptotic, inflammatory, BDNF, Pt, and Aβ40 indicators and neuronal density of CA1, CA2, and CA3 regions of hippocampus in the model of Alzheimer suffering rats induced with trimethyltin chloride
    Damoon Sadoughi · 2019 · Comparative Clinical Pathology
  32. Reparative Effects of Stem Cell Factor and Granulocyte Colony-Stimulating Factor in Aged APP/PS1 Mice
    Xingzhi Guo, Yanying Liu, David Morgan, Li‐Ru Zhao · 2020 · Aging and Disease
  33. CNS cell type–specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation
    Yazi Diana Ke, Gabriella Chan, Kristie Stefanoska, Carol G. Au, Mian Bi, Julius Müller, Magdalena Przybyla, Astrid Feiten, Emmanuel Prikas, Glenda Margaret Halliday et al. · 2019 · Journal of Biological Chemistry
  34. Cleavage of human tau at Asp421 inhibits hyperphosphorylated tau induced pathology in a Drosophila model
    Hao Chi, Sun Lee, Ren-Huei Shiu, Rui Han, Chien-Ping Hsieh, Tzu-Min Wei, Chung‐Chuan Lo, Hui-Yun Chang, Tzu‐Kang Sang · 2020 · Scientific Reports
  35. Extracellular Tau Oligomers Damage the Axon Initial Segment
    Merci N Best, Yunu Lim, Nina N. Ferenc, Nayoung Kim, Lia Min, Dora Bigler Wang, Kamyar Sharifi, Anna E. Wasserman, Sloane A. McTavish, Karsten H. Siller et al. · 2023 · Journal of Alzheimer s Disease
  36. Novel Leptin-Based Therapeutic Strategies to Limit Synaptic Dysfunction in Alzheimer’s Disease
    Jenni Harvey · 2024 · International Journal of Molecular Sciences
  37. Identification of Alzheimer’s Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing
    Meigang Ma, Yuhan Liao, Xiaohua Huang, Chun Zou, Liechun Chen, Lucong Liang, Youshi Meng, Yuan Wu, Donghua Zou · 2022 · Frontiers in Aging Neuroscience
  38. Treatment of epilepsy using a targeted p38γ kinase gene therapy
    Nicolle Morey, Magdalena Przybyla, Julia van der Hoven, Yazi Diana Ke, Fabien Delerue, Janet van Eersel, Lars Matthias Ittner · 2022 · Science Advances
  39. A Connected Network of Interacting Proteins Is Involved in Human-Tau Toxicity in Drosophila
    Sébastien Feuillette, Camille Charbonnier, Thierry Frébourg, Dominique Campion, Magalie Lecourtois · 2020 · Frontiers in Neuroscience
  40. The Disease Associated Tau35 Fragment has an Increased Propensity to Aggregate Compared to Full-Length Tau
    Chen Lyu, Stefano Da Vela, Youssra K. Al‐Hilaly, Karen E. Marshall, Richard Thorogate, Dmitri I. Svergun, Louise C. Serpell, Annalisa Pastore, Diane P. Hanger · 2021 · Frontiers in Molecular Biosciences
  41. Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials
    Xiaoni Zhan, Gehua Wen, Xu Wu, Jiayi Li · 2025 · Translational Neurodegeneration
  42. Biomarker-related phospho-tau217 appears in synapses around Aβ plaques prior to tau tangle in cerebral cortex of preclinical Alzheimer’s disease
    Yu Hirota, Yasufumi Sakakibara, Maho Morishima, Terunori Sano, Manato Hara, Akira Arakawa, Masaki Takao, Shigeo Murayama, Yuko Saito, Michiko Sekiya et al. · 2025 · Cell Reports
  43. Syntaxins 6 and 8 facilitate tau into secretory pathways
    Wei Siang Lee, Daniel C. S. Tan, Yuanyuan Deng, Annika van Hummel, Stefania Ippati, Claire H. Stevens, Paulina Carmona-Mora, Daryl Ariawan, Liming Hou, Holly Stefen et al. · 2021 · Biochemical Journal
  44. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
    Michael Klonarakis, Maya De Vos, Emma K. Woo, Liam T. Ralph, Jonathan S. Thacker, Joana Gil‐Mohapel · 2022 · Neuroscience & Biobehavioral Reviews
  45. c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations
    Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, Miren Ettcheto, Antoni Camins, Carlos Beas‐Zárate, Ruben Dario Castro-Torres, Carme Auladell · 2020 · Journal of Alzheimer s Disease
  46. Guizhi Fuling capsule relieves memory deficits by inhibition of microglial neuroinflammation through blocking JAK2/STAT3 pathway in presenilin1/2 conditional double knockout mice
    Guang Yang, Yuting Tong, Xingyu Wang, Chenyi Zhao, Zongtao Ba, Reaila Ahelijiang, Xinjuan Liu, Waimao Gao, Yan Zhao, Yining Gu et al. · 2023 · Frontiers in Immunology
  47. Study on the Pharmacological Mechanism of Icariin for the Treatment of Alzheimer’s Disease Based on Network Pharmacology and Molecular Docking Techniques
    Dongwei Wang, Jilong Zheng, Xingsheng Sun, Liuwei Xie, Yang Yang · 2023 · Metabolites
  48. Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current
    Sneha Jos, Roshni Poulose, Archanalakshmi Kambaru, Hemanga Gogoi, Nandakumar Dalavaikodihalli Nanjaiah, Balasundaram Padmanabhan, Bhupesh Mehta, Sivaraman Padavattan · 2024 · Journal of Molecular Biology
  49. Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease
    Svit Ferjančič Benetik, Damijan Knez, Aleš Obreza, Urban Košak, Stanislav Gobec · 2024 · Pharmacology & Therapeutics
  50. Inhibition of soluble epoxide hydrolase confers neuroprotection and restores microglial homeostasis in a tauopathy mouse model
    Shuo Wang, Chuangye Qi, Chetan Singh Rajpurohit, Baijayanti Ghosh, Wen Xiong, Baiping Wang, Yanyan Qi, Sung Hee Hwang, Bruce D. Hammock, Hongjie Li et al. · 2025 · Molecular Neurodegeneration
  51. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer’s Disease Mice
    Jing Ma, Yuan Gao, Wei Xue Tang, Wei Huang, Yong Cheng Tang · 2020 · Current Alzheimer Research
  52. Unbiased proteomic profiling reveals the IP3R modulator AHCYL1/IRBIT as a novel interactor of microtubule-associated protein tau
    Lena Wischhof, Aasha Adhikari, Mrityunjoy Mondal, Anaïs Marsal-Cots, Jacek Biernat, Eva‐Maria Mandelkow, Eckhard Mandelkow�, Dan Ehninger, Pierluigi Nicotera, Daniele Bano · 2022 · Journal of Biological Chemistry
  53. TauP301L disengages from the proteosome core complex and neurogranin coincident with enhanced neuronal network excitability
    Katriona L. Hole, Bangfu Zhu, Laura Huggon, Jon T. Brown, Jody M. Mason, Robert J. Williams · 2024 · Cell Death and Disease
  54. Amyloid-Driven Tau Accumulation on Mitochondria Potentially Leads to Cognitive Deterioration in Alzheimer’s Disease
    Mar Cuadrado‐Tejedor, Marta Pérez-González, Rocío Alfaro‐Ruiz, Sara Badesso, Diego Sucunza, María Espelosin, Susana Ursúa, Mercedes Lachén‐Montes, Joaquín Fernández‐Irigoyen, Enrique Santamaría et al. · 2021 · International Journal of Molecular Sciences
  55. Alzheimer’s Disease and Its Possible Evolutionary Origin: Hypothesis
    James F. Whitfield, Kerry Rennie, Balu Chakravarthy · 2023 · Cells
  56. Tau immunotherapy in Alzheimer’s disease and progressive supranuclear palsy
    Nastaran Karimi, Feyza Bayram Catak, Ebru Ozturk Arslan, Amene Saghazadeh, Nima Rezaei · 2022 · International Immunopharmacology
  57. Leptin prevents aberrant targeting of tau to hippocampal synapses via <scp>PI</scp> 3 kinase driven inhibition of <scp>GSK3β</scp>
    Hamilton, Kirsty, Morrow, Kate, Markantoni, Ermione, Harvey, Jenni · 2023 · Journal of Neurochemistry
  58. Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
    Paula J. Bice, Kwangsik T. Nho, Nilüfer Ertekin‐Taner, Andrew J. Saykin · 2026 · Molecular Neurodegeneration
  59. Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer’s disease: associations with Aβ, tau, synaptic proteins and APOE ε4
    Jana Nussbaumer, Aatmika Barve, Valentin Zufferey, Jeanne Espourteille, Tunahan Kirabali, Uwe Konietzko, Daniel Razansky, Axel Rominger, Agneta K. Nordberg, Luc Buée et al. · 2025 · Translational Neurodegeneration
  60. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology
    Vanessa Laversenne, Sameer Nazeeruddin, Emma Källstig, Philippe Colin, Christel Voize, Bernard Laurent Schneider · 2020 · Acta Neuropathologica Communications
  61. Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation
    Goce Taleski, Diana Schuhmacher, Henry K. Su, Jean‐Marie Sontag, Estelle Sontag · 2020 · Journal of Biological Chemistry
  62. A simple human cell model for TAU trafficking and tauopathy-related TAU pathology
    Michael J. Bell, Hans Zempel · 2021 · Neural Regeneration Research
  63. Differential aberrant structural synaptic plasticity in axons and dendrites ahead of their degeneration in tauopathy
    Johanna Jackson, James D. Johnson, S. Meftah, Tracey K. Murray, Zeshan Ahmed, Matteo Fasiolo, Michael L. Hutton, John T. R. Isaac, Michael J. O’Neill, Michael C. Ashby · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  64. Alzheimer's disease: from molecular pathways to therapies
    Jing-Qiu Feng, Ling-Ling Yang, Ya-Xi Luo, Xiu-Qing Yao · 2026 · Molecular Biomedicine
  65. Transgenic Dendra2::tau expression allows in vivo monitoring of tau proteostasis in Caenorhabditis elegans
    Marina Han, Aleen D. Saxton, Heather N. Currey, Sarah M. Waldherr, Nicole F. Liachko, Brian C. Kraemer · 2024 · Disease Models & Mechanisms
  66. Symmetric and Asymmetric Synapses Driving Neurodegenerative Disorders
    Daniel Romaus‐Sanjurjo, Antía Custodia, Marta Aramburu-Núñez, Adrián Posado-Fernández, Laura Vázquez‐Vázquez, Javier Camino-Castiñeiras, Yago Leira, Juan Manuel Pías Peleteiro, José Manuel Aldrey, Alberto Ouro et al. · 2021 · Symmetry
  67. Tau protein is differentially phosphorylated in young‐ and old‐aged rats with experimentally induced hyperthyroidism
    Burak Tan, Ercan Babür, Nihal Toy, Buse Günaydın Türker, Nurcan Dursun, Cem Süer · 2022 · International Journal of Developmental Neuroscience
  68. Unlocking the therapeutic potential of protein kinase inhibitors in neurodegenerative and psychiatric disorders
    Angela Asir R V, Polina Buzaeva, Izhak Michaelevski · 2025 · Exploration of Drug Science
  69. Tauopathies: Emerging discoveries on tau protein, with a special focus on Alzheimer's disease
    Aishwarya Hattiholi, Harsha Hegde, Suhas Kumar Shetty · 2025 · Neuropeptides
  70. Endoplasmic reticulum stress induces Alzheimer disease‐like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein
    Tania Devina, Yu‐Hui Wong, Chiao‐Wan Hsiao, Yu‐Jui Li, Cheng‐Chang Lien, Irene Han-Juo Cheng · 2022 · Journal of Neurochemistry
  71. Tauopathies: The Role of Tau in Cellular Crosstalk and Synaptic Dysfunctions
    Marta Caamaño-Moreno, Ricardo Gargini · 2022 · Neuroscience
  72. Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice
    C. Facal, Iván Fernández Bessone, J. Muñiz, A. Pereyra, Olivia Pedroncini, Indiana Páez-Paz, Ramiro Clerici-Delville, Cayetana Arnaiz, Leandro Urrutia, G. Falasco et al. · 2024 · Molecular Therapy
  73. Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons
    Diede W. M. Broekaart, Abhijeet Sharma, Aarthi Ramakrishnan, Anjalika Chongtham, Dorothee M. Günther, Saraswathi Subramaniyan, Minghui Wang, Vishwendra Patel, Bin Zhang, Lea T. Grinberg et al. · 2025 · Acta Neuropathologica
  74. Tau beyond Tangles: DNA Damage Response and Cytoskeletal Protein Crosstalk on Neurodegeneration
    Megumi Asada‐Utsugi, Makoto Urushitani · 2024 · International Journal of Molecular Sciences
  75. Putative dendritic correlates of chronic traumatic encephalopathy: A preliminary quantitative Golgi exploration
    Allysa Warling, Riri Uchida, Hyun‐Soo Shin, Coby Dodelson, Madeleine E. Garcia, Noah B. Shea‐Shumsky, Sarah E. Svirsky, Morgan J. Pothast, Hunter Kelley, Cynthia Mills Schumann et al. · 2020 · The Journal of Comparative Neurology
  76. FTD-associated mutations in Tau result in a combination of dominant and recessive phenotypes
    Alexander D. Law, Marlène Cassar, Dani M. Long, Eileen S. Chow, Jadwiga Maria Giebultowicz, Anjana Venkataramanan, Roland Strauß, Doris Kretzschmar · 2022 · Neurobiology of Disease
  77. Methyl donor supplementation reduces phospho‐Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy
    Annika van Hummel, Goce Taleski, Jean‐Marie Sontag, Astrid Feiten, Yazi Diana Ke, Lars Matthias Ittner, Estelle Sontag · 2023 · Neuropathology and Applied Neurobiology
  78. AD-Syn-Net: systematic identification of Alzheimer’s disease-associated mutation and co-mutation vulnerabilities via deep learning
    Xingxin Pan, Zeynep Coban‐Akdemir, Ruixuan Gao, Xiaoqian Jiang, Gloria Sheynkman, Erxi Wu, Jason Haitao Huang, Nidhi Sahni, S. Stephen Yi · 2023 · Briefings in Bioinformatics
  79. Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances
    Lei Wang, Rui Zhu, Xiao Zhou, Zhiyong Zhang, Dantao Peng · 2023 · Frontiers in Aging Neuroscience
  80. Tau regulates Arc stability in neuronal dendrites via a proteasome-sensitive but ubiquitin-independent pathway
    Dina W. Yakout, Ankit Shroff, Wei Wei, Vishrut S. Thaker, Zachary D. Allen, Mathew Sajish, Taras Y. Nazarko, Angela M. Mabb · 2024 · Journal of Biological Chemistry
  81. Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation
    Mamen Regalado-Reyes, Ruth Benavides‐Piccione, Isabel Fernaud-Espinosa, Javier DeFelipe, Gonzalo León‐Espinosa · 2020 · Cerebral Cortex Communications
  82. Phenanthroline impairs βAPP processing and expression, increases p53 protein levels and induces cell cycle arrest in human neuroblastoma cells
    Subhamita Maitra, Wannapa Sornjai, Duncan Richard Smith, Bruno Vincent · 2021 · Brain Research Bulletin
  83. Reward motivation and cognitive flexibility in tau null-mutation mice
    Sara Oberrauch, Jeremy A. Metha, Maddison L. Brian, Samuel A. Barnes, Travis J. Featherby, Andrew John Lawrence, Daniël Hoyer, Carsten Murawski, Laura H. Jacobson · 2020 · Neurobiology of Aging
  84. Apolipoprotein E4 as a Novel Treatment Target for Alzheimer’s Disease
    Jamieson Lachlan Jervies, Samuel Peter King, Cenk Suphioglu · 2021 · Cellular Physiology and Biochemistry
  85. Tau Abnormalities and Autophagic Defects in Neurodegenerative Disorders; A Feed-forward Cycle
    Nastaran Samimi, Akiko Asada, Kanae Ando · 2020 · Galen Medical Journal
  86. AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery
    Jeremy D. Baker, Rikki L. Uhrich, T. Strovas, Aleen D. Saxton, B. Kraemer · 2020 · SLAS discovery : advancing life sciences R & D
  87. Synaptic Plasticity in the Hippocampus
    Tim Bliss, Graham L. Collingridge, Samuel F. Cooke, John Georgiou, Richard Morris · 2025 · Oxford University Press eBooks
  88. Multiple and Alternative Sites Make Tau Protein an Adaptable Sticky Surface for the SH3 Domain of Fyn Kinase
    Roberto Tira, Giulia Leo, Laura Prandini, Carlo Giorgio Barracchia, Mariapina D’Onofrio, Luca Mollica, Stefano Capaldi, Michael Assfalg, Francesca Munari · 2025 · Angewandte Chemie International Edition
  89. Chronic Vanadium Exposure Promotes Aggregation of Alpha‐Synuclein, Tau and Amyloid Beta in Mouse Brain
    O. R. Folarin, Funmilayo Eniola Olopade, T. T. Gilbert, Amany Digal Ladagu, Patrícia I. Santos, Oluwaseun Mustapha, Luimommei Zethan Kpasham, James Olukayode Olopade, Tiago F. Outeiro · 2025 · Journal of Neurochemistry
  90. High Level Forebrain Expression of Active Tau Kinase p38γ Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer’s Mice
    Prita Riana Asih, Kristie Stefanoska, Emmanuel Prikas, Arne Ittner · 2022 · Neuroscience
  91. K369I Tau Mice Demonstrate a Shift Towards Striatal Neuron Burst Firing and Goal-directed Behaviour
    Max Mo, Marie E. Jönsson, Miranda A. Mathews, Daniel M. Johnstone, Yazi Diana Ke, Lars Matthias Ittner, Bernard W. Balleine, Teri M. Furlong, Aaron J. Camp · 2020 · Neuroscience
  92. The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy
    Yuwen Chen, Xiaojun Hou, Jiao Pang, Fan Yang, Angcheng Li, Suijin Lin, Na Lin, Tae Ho Lee, Hekun Liu · 2022 · Frontiers in Molecular Neuroscience
  93. Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer’s disease
    Xing Fan, Hao Wang, Jianchao Ping, Mingzhe Li, Jianlan Gu, Wei Qian · 2025 · Biochemical Pharmacology
  94. Small molecule modulation of the p75 neurotrophin receptor promotes dendritic spine resilience to pathogenic tau species and reduces their accumulation
    Tao Yang, Yeonglong Albert Ay, Sukhneet Kaur, Robert R. Butler, Kevin C Tran, Harry Liu, Vanessa F. Langness, Stephen M. Massa, Frank M. Longo · 2026 · Acta Neuropathologica Communications
  95. Tau seeds induce neurofibrillary tangle formation across brain regions via individual-specific connectivity
    Audrey J. Weber, Bernard Ng, Kelsey M. Greathouse, David A. A. Bennett, Shinya Tasaki, Chris Gaiteri, Jeremy H. Herskowitz · 2026 · Neuron
  96. Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
    Eunji Cha, Hak Joong Kim, Sang Min Lim · 2023 · Bulletin of the Korean Chemical Society
  97. Phosphorylation of tau protein based on the activity of kinases and phosphatases in various forms of synaptic plasticity
    Burak Tan, Esra Tufan, Özlem Barutçu, Ezgi Aslan-Gülpınar, Nurcan Dursun, Cem Süer · 2024 · Physiology International
  98. 2d Qsar and Docking Studies on Chalcone - Quinoxaline Variants – a Potential Target for Acetylcholinestrase Inhibitors
    Bala Aakash Velmurugan, Bhuvaneswari Sivaraman, Ramalakshmi Natarajan · 2023 · Research Square
  99. Remote memory engrams are controlled by encoding-specific tau phosphorylation
    Kristie Stefanoska, Emmanuel Prikas, Yijun Lin, Renée Kosonen, Arne Ittner · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  100. 单分子定位超分辨显微技术在神经生物学中的应用(特邀)
    乔钰媛 Qiao Yuyuan, 张亦晴 Zhang Yiqing, 陈太龙 Chen Tailong, 曹健 Cao Jian, 刘建丽 Liu Jianli, 徐帆 Xu Fan · 2025 · Chinese Journal of Lasers